Insider · CIK 0002014301
Andrew Fisher
officer
Files at VRNA (Verona Pharma plc). First filing May 1, 2025, latest Aug 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $2.0M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | Verona Pharma plc | $126k 9,584 shares | -2% | - | |
| 24Weak | Verona Pharma plc | $922k 80,000 shares | -18% | - | |
| 21Weak | Verona Pharma plc | $686k 80,000 shares | -18% | - | |
| 28Weak | Verona Pharma plc | $234k 26,072 shares | -7% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Ordinary Shares | -417,903 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +931,984 | - | - | 931,984 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Ordinary Shares | -931,984 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitderivative | -146,168 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitderivative | -167,056 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | AGrant or award Restricted Share Unitderivative | +618,760 | - | - | 618,760 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitderivative | -618,760 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Share Options (Right to Buy)derivative | -2,240,000 | - | - | 0 | Oct 8, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +20,888 | $0.00 | $0 | 427,487 | Aug 5, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares | -9,584 | $13.14 | $126k | 417,903 | Aug 5, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Stock Unitsderivative | -20,888 | $0.00 | $0 | 146,168 | Aug 5, 2025 |
| Jul 7, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +86,064 | $0.00 | $0 | 446,063 | Jul 9, 2025 |
| Jul 8, 2025 | VRNA Verona Pharma plc | FTax withholding Ordinary Shares | -39,464 | $11.44 | $452k | 406,599 | Jul 9, 2025 |
| Jul 7, 2025 | VRNA Verona Pharma plc | AGrant or award Restricted Share Unitsderivative | +253,120 | $0.00 | $0 | 253,120 | Jul 9, 2025 |
| Jul 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitsderivative | -86,064 | $0.00 | $0 | 167,056 | Jul 9, 2025 |
| Jun 16, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares10b5-1 | +80,000 | $2.01 | $161k | 439,999 | Jun 18, 2025 |
| May 15, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +80,000 | $2.01 | $161k | 439,999 | Jun 18, 2025 |
| Jun 16, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -80,000 | $11.53 | $922k | 359,999 | Jun 18, 2025 |
| May 15, 2025 | VRNA Verona Pharma plc | MOption exercise Share Options (Right to Buy)derivative | -80,000 | $0.00 | $0 | 2,320,000 | Jun 18, 2025 |
| Jun 16, 2025 | VRNA Verona Pharma plc | MOption exercise Share Options (Right to Buy)derivative10b5-1 | -80,000 | $0.00 | $0 | 2,240,000 | Jun 18, 2025 |
| May 15, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares10b5-1 | +80,000 | $2.11 | $169k | 439,999 | May 16, 2025 |
| May 15, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -80,000 | $8.57 | $686k | 359,999 | May 16, 2025 |
| May 15, 2025 | VRNA Verona Pharma plc | MOption exercise Share Options (Right to Buy)derivative10b5-1 | -80,000 | $0.00 | $0 | 2,320,000 | May 16, 2025 |
| Mar 19, 2025 | VRNA Verona Pharma plc | GGift Ordinary Shares | +1 | $0.00 | $0 | 300,001 | May 1, 2025 |
| Apr 29, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +86,064 | $0.00 | $0 | 386,065 | May 1, 2025 |
| Apr 29, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares | -26,072 | $8.98 | $234k | 359,993 | May 1, 2025 |
| Apr 29, 2025 | VRNA Verona Pharma plc | AGrant or award Restricted Share Unitsderivative | +253,120 | $0.00 | $0 | 253,120 | May 1, 2025 |
| Apr 29, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitsderivative | -86,064 | $0.00 | $0 | 167,056 | May 1, 2025 |
| Oct 30, 2024 | VRNA Verona Pharma plc | AGrant or award Ordinary Shares | +300,000 | $0.00 | $0 | 300,000 | Nov 1, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.